Selectin Inhibition Modulates NF-κ B and AP-1 Signaling After Liver Ischemia/Reperfusion

REFERENCES

• Misawa K, Toledo-Pereyra L H, Phillips M L, Garcia-Cirado F J, Lopez-Neblina F, Paez-Rollys A. Role of sialyl Lewis(x) in total hepatic ischemia and reperfusion. J Am Coll Surg 1996; 182: 251–256, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Garcia-Criado F J, Toledo-Pereyra L H, Lopez-Neblina F, Phillips M L, Paez-Rollys A, Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J Am Coll Surg 1995; 181: 327–334, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hicks A E, Nolan S L, Ridger V C, Hellewell P G, Norman K E. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: Complete inhibition of rolling is not required for anti-inflammatory effect. Blood 2003; 101: 3249–3256, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nemoto T, Burne M J, Daniels F, O'Donnell M P, Crosson J, Berens K, Issekutz A, Kasiske B L, Keane W F, Rabb H. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 2001; 60: 2205–2214, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, McDuffie J E, Warner R L, Ward P A. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 2000; 191: 395–402, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Ganster R W, Gambotto A, Shao L, Kaizu T, Wu T, Yagnik G P, Nakao A, Tsoulfas G, Ishikawa T, Okuda T, Geller D A, Murase N. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1175–G1184, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zingarelli B, Hake P W, Yang Z, O'Connor M, Denenberg A, Wong H R. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002; 16: 327–342, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Takeuchi D, Yosidome H, Kato A, et al. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 2004; 39: 699–710, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Das D K, Maulik N. Preconditioning potentiates redox signaling and converts death signal into survival signal. Arch Biochem Biophys 2003; 420: 305–311, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Slee D H, Romano S J, Yu J, Nguyen T N, John J K, Raheja N K, Axe F U, Jones T K, Ripka W C. Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity. J Med Chem 2001; 44: 2094–2107, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Suzuki S, Toledo-Pereyra L H, Rodriguez F J, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55: 1265–1272, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Deryckere F, Gannon F. A one-hour mini-preparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994; 16: 405, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kakkar A K, Lefer D J. Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr Opin Pharmacol 2004; 4: 154–158, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Romano S J, Slee D H. Targeting selectins for the treatment of respiratory diseases. Curr Opin Investig Drugs 2001; 2: 907–913, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Romano S J. Selectin antagonists: Therapeutic potential in asthma and COPD. Treat Respir Med 2005; 4: 85–94, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Toledo-Pereyra L, Lopez-Neblina F, Reuben J, et al. Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion. J Invest Surgery 2004; 17: 303–313, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F A, Toledo-Pereyra L H, Nora D T, Bachulis B L, Ilgenfritz F, Dean R E. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 1998; 45: 404–409, [CSA]
   PubMedGoogle Scholar
• Martinez-Mier G, Toledo-Pereyra L H, McDuffie J E, Warner R L, Hsiao C, Stapleton S R, Ward P A. Exogenous nitric oxide downregulates MIP-2 and MIP-1alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg 2002; 15: 287–296, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jiang Y, Gu X P, Qiu Y D, Sun X M, et al. Ischemic preconditioning decreases C-X-C chemokine expression and neutrophil accumulation early after liver transplantation in rats. World J Gasteroenterol 2003; 9: 2025–2029, [CSA]
   PubMed Web of Science ®Google Scholar
• Winn R K, Paulson J C, Harlan J M. A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol 1994; 267: H2391–2397, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Garcia-Criado F J, Toledo-Pereyra L H, Lopez-Neblina F, Phillips M L, Paez R A, Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J Am Coll Surg 1995; 181: 327–334, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F A, Toledo-Pereyra L H, Bachulis B, Harkema J J, Palma-Vargas J M, Dean R E. Role of L-selectin in liver function and survival in liver function and survival in rats after uncontrolled hemorrhagic shock. Surg Forum 1997; XLVIII: 103–105, [CSA]
   Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, Ward P A. Adhesion molecules in liver ischemia/reperfusion. J Surg Res 2000; 94: 185–193, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, Ward P A. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 2000; 191: 395–400, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F A, Toledo-Pereyra L H, Nora D T, Bachulis B L, Ilgenfritz F, Dean R E. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 1998; 45: 404–409, [CSA]
   PubMedGoogle Scholar
• Ramos-Kelly J, Toledo-Pereyra L H, Jordan J, et al. Multiple selectin blockade with a small molecule inhibitor alters hemorrhagic SOC. J Trauma 2000; 49: 92–100, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kogan T P, Dupre B, Bui H, et al. Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyloxy phenyl] hexane (TBC-1269). J Med Chem 1998; 41: 1099–1111, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Patel K D, Curvelier S L, Wiehler S. Selectins: Critical mediators of leukocyte recruitment. Immunology 2002; 14: 73–81, [CSA]
   Web of Science ®Google Scholar
• Nemoto T, Burne M J, Daniels F, O'Donnell M P, Crosson J, Berens K, Issekutz A, Kasiske B L, Keane W F, Rabb H. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 2001; 60: 2205–2214, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Palma-Vargas J, Toledo-Pereyra L H, Dean R E, et al. Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. J Am Coll Surg 1997; 185: 365–372, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci 2001; 69: 1–15, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lasky L A, Presta L G, Erbe D V. Structure–function aspects of selectin–carbohydrate interactions. Cellular Adhesion; Molecular Definition to Therapeutic Potential, B W Metcalf, B J Dalton, G Poste. Plenum Press, New York 1994; 37–53
   Google Scholar
• Rosen S D, Bertozzi C R. The selectins and their ligands. Curr Opin Cell Biol 1994; 6: 663–673, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Slee D H, Romano S J, Yu J, Nguyen T N, John J K, Raheja N K, Axe F U, Jones T K, Ripka W C. Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity. J Med Chem 2001; 44: 2094–2107, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jassen W, Roake J. The molecular and cellular basis of reperfusion injury following organ transplantation. Transpl Rev 1998; 12: 14–33, [CSA], [CROSSREF]
   Google Scholar
• Grace P A. Ischaemia–reperfusion injury. Br J Surg 1994; 81: 637–643, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra L H, Rivera-Chavez F A, Dean R E. Ischemia y reperfusion hepatica, Reusltados de 21 años de investigacion. Cir Gen 1998; 20: 273–283, [CSA]
   Google Scholar
• Harada N, Sakamoto S, Niwa Y, Nakaya Y. Involvement of adenosine in vascular contractile preconditioning. Am J Physiol 2001; 280: 2911–2919, [CSA]
   Google Scholar
• Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: From the first to the second window of protection. Life Sci 2001; 69: 1–15, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lopez-Neblina F, Paez R A, Toledo-Pereyra L H. Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Tranplant Proc 2001; 27: 1883–1887, [CSA]
   Google Scholar
• Lopez-Neblina F, Paez R A, Garcia-Criado F J, Misawa K, Toledo-Pereyra L H. Exogenous nitric oxide prevents leukocyte rolling and adherence in mesenteric ischemia in the rat. Cir Gen 1995; 17: 90–96, [CSA]
   Google Scholar
• Martinez M G, Toledo-Pereyra L H, Bussell S, Gauvin J, Vercruysse G, Arab A, Harkema J R, Jordan J R, Ward P A. Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion. Transplantation 2000; 70: 1431–1439, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra L H, Ward P A. Requirements of E-selectin in liver ischemia and reperfusion. 2000, Unpublished
   Google Scholar
• Forlow S B, Ley K. Selectin-independent leukocyte rolling and adhesion in mice deficient in E-, P-, and L-selectin and ICAM-1. Am J Physiol Heart Circ Physiol 2001; 280: H634–H641, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Smolen J E, Peterson T K, Koch C, O'Keefe S J, Halon W A, Seo S, Pearson D, Fossett M C, Simon S I. L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein kinase. J Biol Chem 2000; 275: 15876–15884, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brenner B, Weinmann S, Grassme H, Lang F, Linderkamp O, Gulbins E. L-Selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac. Immunology 1997; 92: 214–219, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Junge S, Brenner B, Lepple-Wienhues A, Nilius B, Lang F, Linderkamp O, Gulbins E. Intracellular mechanisms of L-selectin induced capping. Cell Signal 1999; 11: 301–308, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Gozal E, Simakajornboon N, Dausman J, et al. Hypoxia induces selective SAPK/JNK-2–AP-1 pathway activation in the nucleus tractus solitarii of the conscious rat. J Neurochem 1999; 73: 665, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, Hiraoka R, Nishio K, Sato N, Naoki K, Aoki T, Yamaguchi K. Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 2004; 172: 2569–2577, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maulik N, Watanabe M, Engelman D, Engelman R M, Das D K. Oxidative stress adaptation improves postischemic ventricular recovery. Mol Cell Biochem 1995; 144: 67–74, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Maulik N, Engelman R M, Rousou J A, et al. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 1999; 100(Suppl.II)369–375, [CSA]
   PubMedGoogle Scholar